• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Transgenomic Inc

+ Add to Watchlist

TBIO:US

2.6200 USD 0.3500 15.42%

As of 20:10:00 ET on 01/26/2015.

Snapshot for Transgenomic Inc (TBIO)

Open: 2.3300 Day's Range: 2.3200 - 2.7000 Volume: 102,353
Previous Close: 2.2700 52wk Range: 1.4100 - 6.5000 1-Yr Rtn: -56.33%

Stock Chart for TBIO

No chart data available.
  • TBIO:US 2.6200
  • 1D
  • 1M
  • 1Y
2.2700
Interactive TBIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TBIO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.6300
Est. EPS (USD) (12/2014) -1.9000
Est. PEG Ratio -
Market Cap (M USD) 21.18
Shares Outstanding (M) 8.08
30 Day Average Volume 71,905
Price/Book (mrq) 1.8902
Price/Sale (ttm) 0.9679
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TBIO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TBIO

Transgenomic, Inc. provides research tools to the life sciences industry. These tools enable researchers to discover and understand variation in the human genetic code, or genome, in order to accelerate and improve drug development and diagnostics.

Paul KinnonPresident/CEO/Interim CFO/SecyLeon RichardsChief Acctg Officer/Controller
More Company Profile & Key Executives for TBIO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil